Six ‘Designer’ Drugs to Schedule I

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Scheduling Actions

Six ‘Designer’ Drugs to Schedule I

Ken Baumgartner

July 23, 2019 at 22:03:10 ET

A final scheduling order published July 18 placed six synthetic cathinones in Schedule I on a temporary basis pending permanent scheduling (84 Fed. Reg. 34291). Acting under the emergency scheduling authority, the Drug Enforcement Administration announced that the substances would remain in Schedule I until July 18, 2021, or until they are placed in Schedule I under the general sc... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Six ‘Designer’ Drugs to Schedule I

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT